GET DAILY SIGNALSWhy Is Caesarstone Ltd (CSTE) Stock Down -17.07% Today?
Key Takeaways
- Shares of CSTE fell 17.07% to $1.36, down $0.28 from the prior session's close of $1.64.
- The primary catalyst is mounting concern over silicosis-related litigation exposure and the company's decision to delay its earnings release to pursue settlement talks.
- A recent California jury verdict assigned the company a roughly $46.5 million liability, a figure that looms large against its small market capitalization.
- The selloff reflects broader uncertainty around hundreds of pending silica-dust claims rather than any single fundamental business development.
- Traders are now watching the rescheduled third-quarter earnings report set for November 11, 2026, for details on litigation reserves and any settlement.
- For additional context on this stock, explore Price Targets, Earnings, and Forecast pages.
- Discover actionable AI-driven trading ideas in the Trending AI Robots section.
Opening Summary
Caesarstone Ltd. (CSTE), an Israel-based developer and manufacturer of engineered quartz, porcelain, and natural stone surfaces best known for its kitchen countertops, saw its stock tumble sharply in Wednesday's session. The shares fell 17.07%, or $0.28, to $1.36 from a prior close of $1.64, extending a multi-session slide driven by escalating legal uncertainty. The immediate trigger cited by markets is the company's decision to postpone its third-quarter earnings release to allow more time for "settlement discussions related to current legal proceedings" — language investors read as a signal that silica-related litigation costs could escalate.
Silicosis Litigation and Settlement Uncertainty
The heaviest weight on the stock is the company's exposure to silica-dust litigation. Caesarstone and its subsidiaries face a large volume of product-liability claims alleging that fabricators developed silicosis from exposure to respirable crystalline silica while cutting and polishing quartz slabs. As of mid-2026, management had disclosed roughly 800 individual silica-related claims, including approximately 600 in the United States, with a litigation provision of about $51.2 million recorded on its balance sheet.
Investor anxiety intensified after a Los Angeles County jury in late October found the company liable in a silicosis case and awarded approximately $67.3 million in damages, assigning Caesarstone a 69.1% share of fault — a figure equivalent to roughly $46.5 million before any adjustments. Because that single verdict is close to the company's entire market value, which sits below $50 million, the market is repricing the stock to reflect the possibility of further adverse verdicts and settlement costs across the remaining claims.
Delayed Earnings Release Compounds Worries
Adding to the bearish tone, Caesarstone announced on November 3 that it was rescheduling its third-quarter 2026 results and conference call from November 4 to November 11, citing a need for "additional time for settlement discussions related to current legal proceedings." Delays tied to litigation rarely reassure shareholders, particularly for a small-cap name already contending with negative earnings. The move removed the scheduled catalyst for clarity and replaced it with fresh uncertainty about the size and structure of any potential settlement.
Market Context and Trading Activity
The decline unfolded on a notable pickup in trading activity, with intraday volume running well above the prior session's pace and comfortably ahead of recent daily totals. The move was company-specific rather than sector-driven: broad equity indices and most building-products peers did not experience a comparable drawdown, underscoring that this was a reaction to Caesarstone's own legal situation rather than a macro or housing-sector event. On a technical basis, the shares broke decisively below the $1.60 level that had acted as near-term support and traded at or near multi-week lows, reinforcing the bearish momentum.
What Comes Next for CSTE
The next major checkpoint for investors is the rescheduled third-quarter earnings report on November 11, 2026, when management is expected to address the litigation, any updated provisions or reserves, and the status of settlement discussions. Beyond that, the trajectory of CSTE will depend heavily on the pace and outcomes of remaining silica claims, potential insurance recoveries, and the company's ability to manage cash against mounting legal costs. Risks remain elevated on both sides: a favorable settlement framework could stabilize the stock, while additional adverse verdicts or a larger-than-expected reserve build could pressure shares further.
Trending AI Robots
Tickeron's Trending AI Robots page curates the strongest-performing AI trading bots from a broader library of hundreds of automated strategies covering thousands of tickers. These bots differ by strategy, timeframe, performance metrics, and the symbols they trade, allowing users to filter for approaches aligned with their goals. Explore the page to see which AI-driven signals are currently leading the market.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CSTE in upward trend: price may jump up because it broke its lower Bollinger Band on October 29, 2026
CSTE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 39 cases where CSTE's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 77%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +5.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where CSTE advanced for three days, in 161 of 242 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CSTE as a result. In 60 of 69 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
CSTE moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CSTE crossed bearishly below the 50-day moving average on October 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSTE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for CSTE entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.526) is normal, around the industry mean (2.990). P/E Ratio (-0.397) is within average values for comparable stocks, (25.807). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (1.215). CSTE has a moderately high Dividend Yield (0.610) as compared to the industry average of (0.084). CSTE's P/S Ratio (0.260) is slightly lower than the industry average of (1.867).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. CSTE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CSTE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of engineered quartz surfaces which installs as countertops in residential kitchens
Industry BuildingProducts
Advertisement